ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

ABOS Acumen Pharmaceuticals Inc

2,16
0,02 (0,93%)
26 Jun 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Acumen Pharmaceuticals Inc ABOS NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,02 0,93% 2,16 18:19:26
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
2,13 2,08 2,265 2,16 2,14
mais cotações »

Notícias Recentes

Data Hora Fonte Título
14/05/202408:00GLOBEAcumen Pharmaceuticals Reports First Quarter 2024 Financial..
13/05/202417:00GLOBEAcumen Pharmaceuticals to Participate in the H.C. Wainwright..
08/05/202418:47GLOBEAcumen Pharmaceuticals to Participate in the 2024 Bank of..
08/05/202409:00GLOBEAcumen Pharmaceuticals Announces First Patient Dosed in..
07/05/202417:00GLOBEAcumen Pharmaceuticals to Report First Quarter Results on..
16/04/202409:00GLOBEAcumen Pharmaceuticals Presents First Comprehensive Clinical..
04/04/202409:00GLOBEAcumen Pharmaceuticals Collaborates with Lonza to Advance..
26/03/202408:00GLOBEAcumen Pharmaceuticals Reports Financial Results for the..
21/03/202409:00GLOBEAcumen Pharmaceuticals to Present Deeper Insights, Including..
19/03/202417:00GLOBEAcumen Pharmaceuticals to Report Fourth Quarter and Year-End..
12/03/202417:00GLOBEAcumen Pharmaceuticals to Participate in the Stifel 2024 CNS..
08/03/202410:50GLOBEAcumen Pharmaceuticals Presents Sabirnetug (ACU193) Fluid..
21/02/202410:00GLOBEAcumen Pharmaceuticals to Present Sabirnetug (ACU193) Fluid..
01/02/202409:00GLOBEAcumen Pharmaceuticals Appoints Dr. James Doherty as..
04/01/202418:15GLOBEAcumen Pharmaceuticals to Present at the 42nd Annual J.P...
13/11/202309:00GLOBEAcumen Pharmaceuticals Secures $50.0 Million Credit Facility..
07/11/202318:01GLOBEAcumen Pharmaceuticals to Participate in the Stifel..
06/11/202318:01GLOBEAcumen Pharmaceuticals to Report Third Quarter Financial..
06/11/202309:30GLOBEAcumen Pharmaceuticals, Inc. and Halozyme Enter Global..
02/11/202317:00GLOBEAcumen Pharmaceuticals to Participate in the UBS Biopharma..
27/10/202310:25GLOBEAcumen Pharmaceuticals Presents Late-Breaker Phase 1 Updates..
04/10/202309:00GLOBEAcumen Pharmaceuticals to Present Deeper Insights from..
19/09/202317:00GLOBEAcumen Pharmaceuticals to Participate in the Cantor Global..
06/09/202317:00GLOBEAcumen Pharmaceuticals to Participate in the H.C. Wainwright..
08/08/202308:00GLOBEAcumen Pharmaceuticals Reports Second Quarter 2023 Financial..
01/08/202317:00GLOBEAcumen Pharmaceuticals to Report Second Quarter Financial..
18/07/202323:31GLOBEAcumen Announces Pricing of Upsized $130 Million Public..
17/07/202317:53GLOBEAcumen Pharmaceuticals Announces Proposed Public Offering of..
17/07/202308:00GLOBEAcumen Pharmaceuticals to Hold Conference Call to Discuss..
16/07/202304:00GLOBEAcumen Pharmaceuticals Presents Positive Topline Results..